Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 320

Showing 26-50 of 320 citing articles:

Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing
Mei‐Ling Cheng, Guodong Liang, Zongyi Yin, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5497-5512
Closed Access | Times Cited: 37
Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
Jessica J. Holster, Marouan El Hassnaoui, Stijn Franssen, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 9, pp. 5528-5538
Open Access | Times Cited: 31
Engineering neoantigen vaccines to improve cancer personalized immunotherapy
Zaoqu Liu, Jinxiang Lv, Qin Dang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5607-5623
Open Access | Times Cited: 30
CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m6A) modification
Shurui Zhou, Kege Yang, Shaojie Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway
Menghua Zhou, Hongjun Yu, Miaoyu Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 777-790
Open Access | Times Cited: 7
UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway
Huhu Zhang, Jiahua Yang, Qinghang Song, et al.
Acta Biochimica et Biophysica Sinica (2024) Vol. 56, Iss. 2, pp. 199-209
Open Access | Times Cited: 7
Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma
Yanjie Zhong, Xi-Mei Luo, Fei Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Cuproptosis-related genes score and its hub gene GCSH: A novel predictor for cholangiocarcinomas prognosis based on RNA seq and experimental analyses
Rui He, Yihu Li, Pengcheng Jiao, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1551-1567
Open Access | Times Cited: 6
Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma
YeXing Huang, ZeFeng Du, Anna Kan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
Hefei Ren, Chang Liu, Cheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study
Irene Bargellini, Cristina Mosconi, G Pizzi, et al.
CardioVascular and Interventional Radiology (2020) Vol. 43, Iss. 9, pp. 1305-1314
Closed Access | Times Cited: 49
Milestones in the pathogenesis and management of primary liver cancer
Jean–Charles Nault, Ann‐Lii Cheng, Bruno Sangro, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 209-214
Open Access | Times Cited: 48
A 3‐Decade, Single‐Center Experience of Liver Transplantation for Cholangiocarcinoma: Impact of Era, Tumor Size, Location, and Neoadjuvant Therapy
Takahiro Ito, James Butler, Daisuke Noguchi, et al.
Liver Transplantation (2021) Vol. 28, Iss. 3, pp. 386-396
Closed Access | Times Cited: 36
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
Xiangyu Wang, Wenwei Zhu, Zheng Wang, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 260-276
Open Access | Times Cited: 36
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer
Stephen P. Hack, Wendy Verret, Sohail Mulla, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 34
Radiomics-Based Preoperative Prediction of Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma Using Contrast-Enhanced Computed Tomography
Shuaitong Zhang, Shengyu Huang, Wei He, et al.
Annals of Surgical Oncology (2022) Vol. 29, Iss. 11, pp. 6786-6799
Closed Access | Times Cited: 24
Circular RNAs in cholangiocarcinoma
Wenwei Liao, Qingbo Feng, Huixian Liu, et al.
Cancer Letters (2022) Vol. 553, pp. 215980-215980
Closed Access | Times Cited: 23
Current progress in perioperative chemotherapy for biliary tract cancer
Tatsuya Ioka, Yoshitaro Shindo, Makoto Ueno, et al.
Annals of Gastroenterological Surgery (2023) Vol. 7, Iss. 4, pp. 565-571
Open Access | Times Cited: 16
PTEN deficiency facilitates gemcitabine efficacy in cancer by modulating the phosphorylation of PP2Ac and DCK
Tianyi Jiang, Xiao-Wen Cui, Tian-Mei Zeng, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 704
Closed Access | Times Cited: 16
An Inflammatory Checkpoint Generated by IL1RN Splicing Offers Therapeutic Opportunity for KRAS-Mutant Intrahepatic Cholangiocarcinoma
Mao Zhang, Yingying Huang, Jiaomeng Pan, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2248-2269
Closed Access | Times Cited: 16
Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases
Zeyu Wu, Xiao Yu, Shuijun Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical–Radiomic Model
Francesco Fiz, Noemi Rossi, Serena Langella, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4204-4204
Open Access | Times Cited: 13
m6A demethylase ALKBH5 maintains stemness of intrahepatic cholangiocarcinoma by sustaining BUB1B expression and cell proliferation
Yuan Gao, Miao Yu, Zengyuan Liu, et al.
Translational Oncology (2024) Vol. 41, pp. 101858-101858
Open Access | Times Cited: 5
Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells
Qi Zhang, Jixiang Zhou, Denggao Zhai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 5, pp. 167152-167152
Closed Access | Times Cited: 5
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
Shiwei Yue, Yunpu Zhang, Wei Zhang
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1089-1111
Open Access | Times Cited: 5

Scroll to top